|
[1]
|
Dolgin, E. (2015) The Myopia Boom. Nature, 519, 276-278. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Morgan, I. and Rose, K. (2005) How Genetic Is School Myopia? Progress in Retinal and Eye Research, 24, 1-38. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Morgan, I.G., French, A.N., Ashby, R.S., Guo, X., Ding, X., He, M., et al. (2018) The Epidemics of Myopia: Aetiology and Prevention. Progress in Retinal and Eye Research, 62, 134-149. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Morgan, I.G., He, M. and Rose, K.A. (2017) Epidemic of Pathologic Myopia: What Can Laboratory Studies and Epidemiology Tell Us? Retina, 37, 989-997. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Morgan, I.G., Ohno-Matsui, K. and Saw, S. (2012) Myopia. The Lancet, 379, 1739-1748. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Pan, C., Ramamurthy, D. and Saw, S. (2011) Worldwide Prevalence and Risk Factors for Myopia. Ophthalmic and Physiological Optics, 32, 3-16. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Holden, B.A., Fricke, T.R., Wilson, D.A., Jong, M., Naidoo, K.S., Sankaridurg, P., et al. (2016) Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology, 123, 1036-1042. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Stevens, G.A., White, R.A., Flaxman, S.R., Price, H., Jonas, J.B., Keeffe, J., et al. (2013) Global Prevalence of Vision Impairment and Blindness: Magnitude and Temporal Trends, 1990-2010. Ophthalmology, 120, 2377-2384. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
井云, 李清波, 吴仲英. 《高度近视防控专家共识(2023)》解读(上) [J]. 中国眼镜科技杂志, 2023(11): 108-111.
|
|
[10]
|
Xu, L., Zhuang, Y., Zhang, G., Ma, Y., Yuan, J., Tu, C., et al. (2021) Design, Methodology, and Baseline of Whole City-Million Scale Children and Adolescents Myopia Survey (CAMS) in Wenzhou, China. Eye and Vision, 8, Article No. 31. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
李遥, 周希瑗. 青少年近视影响因素及防控方法进展[J]. 临床医学进展, 2023, 13(5): 7325-7334.
|
|
[12]
|
Morgan, I.G., Wu, P., Ostrin, L.A., Tideman, J.W.L., Yam, J.C., Lan, W., et al. (2021) IMI Risk Factors for Myopia. Investigative Opthalmology & Visual Science, 62, Article 3. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Jonas, J.B., Ang, M., Cho, P., Guggenheim, J.A., He, M.G., Jong, M., et al. (2021) IMI Prevention of Myopia and Its Progression. Investigative Opthalmology & Visual Science, 62, Article 6. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Huang, J., Wen, D., Wang, Q., McAlinden, C., Flitcroft, I., Chen, H., et al. (2016) Efficacy Comparison of 16 Interventions for Myopia Control in Children: A Network Meta-Analysis. Ophthalmology, 123, 697-708. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Brodstein, R.S., Brodstein, D.E., Olson, R.J., Hunt, S.C. and Williams, R.R. (1984) The Treatment of Myopia with Atropine and Bifocals. A Long-Term Prospective Study. Ophthalmology, 91, 1373-1378. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Gong, Q., Janowski, M., Luo, M., Wei, H., Chen, B., Yang, G., et al. (2017) Efficacy and Adverse Effects of Atropine in Childhood Myopia: A Meta-Analysis. JAMA Ophthalmology, 135, 624-630. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Chua, W., Balakrishnan, V., Chan, Y., Tong, L., Ling, Y., Quah, B., et al. (2006) Atropine for the Treatment of Childhood Myopia. Ophthalmology, 113, 2285-2291. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Chia, A., Chua, W., Cheung, Y., Wong, W., Lingham, A., Fong, A., et al. (2012) Atropine for the Treatment of Childhood Myopia: Safety and Efficacy of 0.5%, 0.1%, and 0.01% Doses (Atropine for the Treatment of Myopia 2). Ophthalmology, 119, 347-354. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Yam, J.C., Jiang, Y., Tang, S.M., et al. (2019) Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control. Ophthalmology, 126, 113-124.
|
|
[20]
|
Ambache, N. (1955) The Use and Limitations of Atropine for Pharmacological Studies on Autonomic Effectors. Pharmacological Reviews, 7, 467-494.
|
|
[21]
|
Kaiti, R. (2022) Role of Atropine in the Control of Myopia Progression—A Review. Beyoglu Eye Journal, 7, 157-166. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Fang, P., Chung, M., Yu, H. and Wu, P. (2010) Prevention of Myopia Onset with 0.025% Atropine in Premyopic Children. Journal of Ocular Pharmacology and Therapeutics, 26, 341-345. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Kumaran, A., Htoon, H.M., Tan, D. and Chia, A. (2015) Analysis of Changes in Refraction and Biometry of Atropine-and Placebo-Treated Eyes. Investigative Opthalmology & Visual Science, 56, 5650-5655. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
McBrien, N.A., Arumugam, B., Gentle, A., Chow, A. and Sahebjada, S. (2011) The M4 Muscarinic Antagonist MT‐3 Inhibits Myopia in Chick: Evidence for Site of Action. Ophthalmic and Physiological Optics, 31, 529-539. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Upadhyay, A. and Beuerman, R.W. (2020) Biological Mechanisms of Atropine Control of Myopia. Eye & Contact Lens: Science & Clinical Practice, 46, 129-135. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Barathi, V.A. and Beuerman, R.W. (2011) Molecular Mechanisms of Muscarinic Receptors in Mouse Scleral Fibroblasts: Prior to and after Induction of Experimental Myopia with Atropine Treatment. Molecular Vision, 17, 680-692.
|
|
[27]
|
Wess, J. (1996) Molecular Biology of Muscarinic Acetylcholine Receptors. Critical Reviews™ in Neurobiology, 10, 69-99. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Caulfield, M.P. and Birdsall, N.J. (1998) International Union of Pharmacology. XVII. Classification of Muscarinic Acetyl-Choline Receptors. Pharmacological Reviews, 50, 279-290.
|
|
[29]
|
Volpicelli, L.A. and Levey, A.I. (2004) Muscarinic Acetylcholine Receptor Subtypes in Cerebral Cortex and Hippocampus. Progress in Brain Research, 145, 59-66. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Abrams, P., Andersson, K., Buccafusco, J.J., Chapple, C., de Groat, W.C., Fryer, A.D., et al. (2006) Muscarinic Receptors: Their Distribution and Function in Body Systems, and the Implications for Treating Overactive Bladder. British Journal of Pharmacology, 148, 565-578. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Gimbel, H.V. (1973) The Control of Myopia with Atropine. Canadian Journal of Ophthalmology, 8, 527-532.
|
|
[32]
|
Lind, G.J., Chew, S.J., Marzani, D., et al. (1998) Muscarinic Acetylcholine Receptor Antagonists Inhibit Chick Scleral Chondrocytes. Investigative Ophthalmology & Visual Science, 39, 2217-2231.
|
|
[33]
|
Dartt, D.A. (2001) Regulation of Lacrimal Gland Secretion by Neurotransmitters and the EGF Family of Growth Factors. Experimental Eye Research, 73, 741-752. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Collison, D.J., Coleman, R.A., James, R.S., et al. (2000) Characterization of Muscarinic Receptors in Human Lens Cells by Pharmacologic and Molecular Techniques. Investigative Ophthalmology & Visual Science, 41, 2633-2641.
|
|
[35]
|
Barathi, V.A., Weon, S.R. and Beuerman, R.W. (2009) Expression of Muscarinic Receptors in Human and Mouse Sclera and Their Role in the Regulation of Scleral Fibroblasts Proliferation. Molecular Vision, 15, 1277-1293.
|
|
[36]
|
Yue, J. and Mulder, K.M. (2001) Transforming Growth Factor-Β Signal Transduction in Epithelial Cells. Pharmacology & Therapeutics, 91, 1-34. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Hackel, P.O., Zwick, E., Prenzel, N. and Ullrich, A. (1999) Epidermal Growth Factor Receptors: Critical Mediators of Multiple Receptor Pathways. Current Opinion in Cell Biology, 11, 184-189. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Rude Voldborg, B., Damstrup, L., Spang-Thomsen, M. and Skovgaard Poulsen, H. (1997) Epidermal Growth Factor Receptor (EGFR) and EGFR Mutations, Function and Possible Role in Clinical Trials. Annals of Oncology, 8, 1197-1206. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
吴劲松, 李姝蓉, 熊伟伟. 阿托品对大鼠巩膜成纤维细胞增殖和凋亡的影响及其机制[J]. 眼科新进展, 2023, 43(4): 266-269.
|
|
[40]
|
余嘉珍, 莫亚. 近视小鼠巩膜成纤维细胞的基因表达谱:基于单细胞RNA测序的生物信息学分析[J]. 南方医科大学学报, 2021, 41(7): 1087-1092.
|
|
[41]
|
Yang, Q., Lv, S., Zhu, H., Zhang, L., Li, H. and Song, S. (2022) A Potential Research Target for Scleral Remodeling: Effect of Mir-29a on Scleral Fibroblasts. Ophthalmic Research, 65, 566-574. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Wu, J., Zhao, Y., Fu, Y., Li, S. and Zhang, X. (2021) Effects of Lumican Expression on the Apoptosis of Scleral Fibroblasts: in Vivo and in Vitro Experiments. Experimental and Therapeutic Medicine, 21, Article No. 495. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Zhao, F., Zhou, Q., Reinach, P.S., Yang, J., Ma, L., Wang, X., et al. (2018) Cause and Effect Relationship between Changes in Scleral Matrix Metallopeptidase-2 Expression and Myopia Development in Mice. The American Journal of Pathology, 188, 1754-1767. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Liu, H., Kenning, M.S., Jobling, A.I., McBrien, N.A. and Gentle, A. (2017) Reduced Scleral TIMP-2 Expression Is Associated with Myopia Development: TIMP-2 Supplementation Stabilizes Scleral Biomarkers of Myopia and Limits Myopia Development. Investigative Opthalmology & Visual Science, 58, 1971-1981. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
郑卓涛, 张凌月, 封炎, 等. 低浓度阿托品滴眼液对近视儿童青少年视网膜与脉络膜厚度及微循环的影响[J]. 眼科新进展, 2023, 43(11): 887-892.
|
|
[46]
|
刘素江, 韩惠芳, 韩爱军, 等. 阿托品眼药水对中度近视豚鼠视网膜功能的作用研究[J]. 中国临床药理学杂志, 2019, 35(15): 1606-1608.
|
|
[47]
|
Xu, H., Ye, L., Peng, Y., Yu, T., Li, S., Weng, S., et al. (2023) Potential Choroidal Mechanisms Underlying Atropine’s Antimyopic and Rebound Effects: A Mediation Analysis in a Randomized Clinical Trial. Investigative Opthalmology & Visual Science, 64, Article 13. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Xiong, S., He, X., Zhang, B., Deng, J., Wang, J., Lv, M., et al. (2020) Changes in Choroidal Thickness Varied by Age and Refraction in Children and Adolescents: A 1-Year Longitudinal Study. American Journal of Ophthalmology, 213, 46-56. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Jin, P., Zou, H., Xu, X., Chang, T.C., Zhu, J., Deng, J., et al. (2019) Longitudinal Changes in Choroidal and Retinal Thicknesses in Children with Myopic Shift. Retina, 39, 1091-1099. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Wallman, J. and Winawer, J. (2004) Homeostasis of Eye Growth and the Question of Myopia. Neuron, 43, 447-468. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Nickla, D.L., Zhu, X. and Wallman, J. (2013) Effects of Muscarinic Agents on Chick Choroids in Intact Eyes and Eyecups: Evidence for a Muscarinic Mechanism in Choroidal Thinning. Ophthalmic and Physiological Optics, 33, 245-256. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Ji, Y., Kang, Y. and Chen, S. (2023) Effects of Endogenous Dopamine Induced by Low Concentration Atropine Eye Drops on Choroidal Neovascularization in High Myopia Mice. International Journal of Ophthalmology, 16, 1034-1040. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Chakroborty, D., Sarkar, C., Lu, K., Bhat, M., Dasgupta, P.S. and Basu, S. (2016) Activation of Dopamine D1 Receptors in Dermal Fibroblasts Restores Vascular Endothelial Growth Factor-A Production by These Cells and Subsequent Angiogenesis in Diabetic Cutaneous Wound Tissues. The American Journal of Pathology, 186, 2262-2270. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
Nöll, G.N., Billek, M., Pietruck, C. and Schmidt, K. (1994) Inhibition of Nitric Oxide Synthase Alters Light Responses and Dark Voltage of Amphibian Photoreceptors. Neuropharmacology, 33, 1407-1412. [Google Scholar] [CrossRef] [PubMed]
|
|
[55]
|
Tsuyama, Y., Nöll, G.N. and Schmidt, K. (1993) L-Arginine and Nicotinamide Adenine Dinucleotide Phosphate Alter Dark Voltage and Accelerate Light Response Recovery in Isolated Retinal Rods of the Frog (Rana temporaria). Neuroscience Letters, 149, 95-98. [Google Scholar] [CrossRef] [PubMed]
|
|
[56]
|
Shiells, R. and Falk, G. (1992) Retinal On-Bipolar Cells Contain a Nitric Oxide-Sensitive Guanylate Cyclase. NeuroReport, 3, 845-848. [Google Scholar] [CrossRef] [PubMed]
|
|
[57]
|
Sato, M., Ohtsuka, T. and Stell, W.K. (2011) Endogenous Nitric Oxide Enhances the Light-Response of Cones during Light-Adaptation in the Rat Retina. Vision Research, 51, 131-137. [Google Scholar] [CrossRef] [PubMed]
|
|
[58]
|
Ashby, R., Ohlendorf, A. and Schaeffel, F. (2009) The Effect of Ambient Illuminance on the Development of Deprivation Myopia in Chicks. Investigative Opthalmology & Visual Science, 50, 5348-5354. [Google Scholar] [CrossRef] [PubMed]
|
|
[59]
|
Wang, Y., Ding, H., Stell, W.K., Liu, L., Li, S., Liu, H., et al. (2015) Exposure to Sunlight Reduces the Risk of Myopia in Rhesus Monkeys. PLOS ONE, 10, e0127863. [Google Scholar] [CrossRef] [PubMed]
|
|
[60]
|
Rose, K.A., Morgan, I.G., Ip, J., Kifley, A., Huynh, S., Smith, W., et al. (2008) Outdoor Activity Reduces the Prevalence of Myopia in Children. Ophthalmology, 115, 1279-1285. [Google Scholar] [CrossRef] [PubMed]
|
|
[61]
|
French, A.N., Ashby, R.S., Morgan, I.G. and Rose, K.A. (2013) Time Outdoors and the Prevention of Myopia. Experimental Eye Research, 114, 58-68. [Google Scholar] [CrossRef] [PubMed]
|
|
[62]
|
Carr, B.J. and Stell, W.K. (2016) Nitric Oxide (NO) Mediates the Inhibition of Form-Deprivation Myopia by Atropine in Chicks. Scientific Reports, 6, Article No. 9. [Google Scholar] [CrossRef] [PubMed]
|
|
[63]
|
Thomson, K., Kelly, T., Karouta, C., Morgan, I. and Ashby, R. (2021) Insights into the Mechanism by Which Atropine Inhibits Myopia: Evidence against Cholinergic Hyperactivity and Modulation of Dopamine Release. British Journal of Pharmacology, 178, 4501-4517. [Google Scholar] [CrossRef] [PubMed]
|
|
[64]
|
Schwahn, H.N., Kaymak, H. and Schaeffel, F. (2000) Effects of Atropine on Refractive Development, Dopamine Release, and Slow Retinal Potentials in the Chick. Visual Neuroscience, 17, 165-176. [Google Scholar] [CrossRef] [PubMed]
|
|
[65]
|
Dowling, J.E. and Ehinger, B. (1978) The Interplexiform Cell System. I. Synapses of the Dopaminergic Neurons of the Goldfish Retina. Proceedings of the Royal Society B: Biological Sciences, 201, 7-26.
|
|
[66]
|
Mitsuma, T., Rhue, H., Hirooka, Y., et al. (1998) Distribution of Dopamine Transporter in the Rat: An Immunohistochemical Study. Endocrine Regulations, 32, 71-75.
|
|
[67]
|
Cohen, J., Hadjiconstantinou, M. and Neff, N.H. (1983) Activation of Dopamine-Containing Amacrine Cells of Retina: Light-Induced Increase of Acidic Dopamine Metabolites. Brain Research, 260, 125-127. [Google Scholar] [CrossRef] [PubMed]
|
|
[68]
|
Megaw, P., Morgan, I. and Boelen, M. (2001) Vitreal Dihydroxyphenylacetic Acid (DOPAC) as an Index of Retinal Dopamine Release. Journal of Neurochemistry, 76, 1636-1644. [Google Scholar] [CrossRef] [PubMed]
|
|
[69]
|
Lee, S.S.Y., Mackey, D.A., Lingham, G., Crewe, J.M., Richards, M.D., Chen, F.K., et al. (2020) Western Australia Atropine for the Treatment of Myopia (WA‐ATOM) Study: Rationale, Methodology and Participant Baseline Characteristics. Clinical & Experimental Ophthalmology, 48, 569-579. [Google Scholar] [CrossRef] [PubMed]
|